Vascular access nursing: Standards of care, and strategies in the prevention of infection: A primer on central venous catheters (Part 2 of a 3-Part series)

JAVA - Journal of the Association for Vascular Access

Volumn 12, Issue 1, 2007, Pages 19-27

  Richardson, Deborah ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; POLYURETHAN; SILICONE;

ANTIBIOTIC THERAPY; ARTICLE; ASEPSIS; BLOOD SAMPLING; BLOOD TRANSFUSION; CATHETER INFECTION; CENTRAL VENOUS CATHETER; FLUID THERAPY; HEALTH CARE; HEALTH CARE PERSONNEL; HEMODYNAMIC MONITORING; INFECTION COMPLICATION; INFECTION PREVENTION; INTRAVENOUS ADMINISTRATION; NURSING CARE; PARENTERAL NUTRITION; PATIENT CARE; PRACTICE GUIDELINE; STANDARDIZATION; VASCULAR ACCESS; VASCULAR ACCESS DEVICE;

EID: 34247589290     PISSN: 15528855     EISSN: 15571289     Source Type: Journal    
DOI: 10.2309/java.12-1-7     Document Type: Article

References (33)

1. Bestul M, Vandenbussche H. Antibiotic lock technique: review of the literature. Pharmacother. 2005;25:211-227.
2. Safdar N, Kluger D, Maki D. A review of risk factors for catheter-related bloodstream infections caused by percutaneously inserted, non-cuffed central venous catheters: implications for preventive strategies. Medicine. 2002;81:466-479.
3. Crawford A, Fuhr J, Rao B. Cost-benefit analysis of chlorhexidine dressing in the prevention of catheter-related bloodstream infections. Infect Control Hosp Epidemiol. 2004;25:668-674.
4. Brown M. The impact of safety product use on catheter-related infection. J Infusion Nurs. 2004;27:245-250.
5. Pieger-Mooney S. Innovations in central venous access device insertion. J Infusion Nurs. 2005;28(3S):S7-S12.
6. Goodwin ML. The Seldinger method for PICC insertion. J Intravenous Nurs. 1989;12:238-243.
7. Crnich CJ, Maki DG. The promise of novel technology for the prevention of intravascular device-related bloodstream infection I. Pathogenesis and short-term devices. Healthcare Epidemiol. 2002;34:1232-1242.
8. Darouiche R, Berger D, Khardori N, Robertson C, et al. Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters: a randomized, controlled trial. Ann Surg. 2005;242:193-200.
9. Introduction to Infusion Therapy. In: Handbook of Infusion Therapy. Springhouse, PA: Springhouse Corp; 1999:2-7.
10. Maki DG, Ringer M, Alvarado CJ. Prospective randomized trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infections associated with central venous and arterial catheters. Lancet. 19991;338:339-343.
11. Infusion Nurses Society. Infusion nurses standards of practice. J Infusion Nurs. 2006;29(1S).
12. Adams D, Quayum M, Worthington T, et al. Evaluating a 2% chlorhexidine gluconate in 70% isopropyl alcohol skin disinfectant. J Hosp Infect. 2005;61:287-290.
13. Elliott T, Moss H, Tebbs S, et al. Novel approach to investigate a source of microbial contamination of central venous catheters. Eur J Clin Microbiol Infect Dis. 1997;16:210-213.
14. Raad I, Hohn D, Gilbreath B, et al. Prevention of central venous catheter-related infection by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994;15:231-238.
15. Lacroix J, Gauvin F. Habit and hub. Crit Care Med 2003;31:1583-1584.
16. Tilton D. Central venous access device infections in the critical care unit. Crit Care Nurs Q. 2006;29:117-122.
17. Maki D, Stolz S, Wheeler S, et al. Prevention of central venous catheter-related bloodstream infections by use of antiseptic impregnated catheters: a randomized controlled trial. Ann Intern Med. 1997;127:257-266.
18. Rand I, Darouiche R, Dupuis J, et al. Central venous catheters coated with minocycine and rifampin for the prevention of catheter-related colonization and bloodstream infection. A randomized, double blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med. 1997; 127:267-274.
19. Hanna H, Benjamin R, Chatzinikolaou I, et al. Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related blood-stream infection in cancer patients. A prospective, randomized clinical trial. J Clin Oncol. 2004;22:3163-3171.
20. Bassetti S, Hu J, D'Agostino R, et al. Prolonged antimicrobial activity of a catheter containing chlorhexidine and silver sulfadiazine extends protection against catheter infection in vivo. Antimicrob Agents Chemother. 2001;45:1535-1538.
21. Nabulsi N, Hanna H, Rand I, et al. Devices impregnated with novel antiseptic agents: broad-spectrum activity and prolonged antimicrobial durability. Abstract presented at: 41st Interscience Conference on Antimicrobial Agents and Chemotherapy; September 22-25, 2001; Chicago, IL: Abstract K 1459.
22. Logghe C, Van Ossel C, D'Hare W, et al. Evaluation of chlorhexidine and silver sulfadiazine impregnated central venous catheter for prevention of bloodstream infection in leukemia patients. A randomized controlled trial. J Hosp Infect. 1997;37:145-156.
23. Yucel N, Lefering R, Maegele M, Max M, et al Reduced colonization and infections with miconazole-rifampicin modified central venous catheters: a randomized, controlled clinical trial. J Antimicrob Chemother. 2004;54:1109-1115.
24. O'Grady NP, Alexander M, Dillinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep. 2002;51(RR-10):1-29.
25. Agency for Healthcare Research and Quality. Making healthcare safer: a critical analysis of patient safety practices. Evidence Report/ Technology Assessment, No. 43. Available at: http://www.AHRQ.gov/cinic/ epoix.html. Accessed May 17, 2006.
26. Guggenbichler J, Boswald M, Luganer S, et al. A new technology of microdispersed silver in polyurethane induces antimicrobial activity in central venous catheters. Infect. 1997;27(suppl 1):S16-S23.
27. Bach A, Eberhardt H, Frick A, et al. Efficacy of silver-coating central venous catheters in reducing bacterial colonization. Crit Care Med. 1999;27:515-521.
28. Bong J, Kite P, Wilco M, et al. Prevention of catheter-related bloodstream infection by silver iontophoretic central venous catheters: a randomized controlled trial. J Clin Pathol. 2003;56:731-735.
29. Frandel D, Rickard C, Thomas P, et al. A prospective randomized trial of rifampin-minocycline coated and silver-platinum-carbon impregnated central venous catheters. Crit Care Med. 2006;34:668-675.
30. Ranucci M, Guiseppe I, Giomarelli P, Parusi M, et al. Impact of oligon central venous catheters on catheter colonization and catheter-related bloodstream infections. Crit Care Med. 2003;31:52-59.
31. Institute for Healthcare Improvement. 100,000 Lives Campaign. 2005. Available at: http://www.IHI.org/HIH/Programs/Campaign/. Accessed August 25, 2006.
32. Kline A. Pediatric catheter-related bloodstream infection: latest strategies to decrease risk. AACN Clin Issues Adv Prac Acute Crit Care. 2005;16:185-198.
33. Hanchett M. Infusion nurses' greatest barrier: the lack of evidence to support evidence-based practice. Top Adv Prac Nurs eJournal. 2005;5(3):1-6.